Indian scientists develop 1st human gene therapy for Haemophilia A
In a significant medical feat, Indian scientists have developed the first-in-human gene therapy using lentiviral vectors for ...
DBT, CSCR develop 1st human gene therapy for Haemophilia A in India
Haemophilia is a severe bleeding disorder caused by the deficiency of clotting Factor VIII, leading to spontaneous internal ...
The Financial Express15h
First-in-human indigenous gene therapy for Hemophilia A shows significant positive outcomes
Current treatments require frequent Factor VIII replacement therapy, which faces challenges such as high costs, venous access ...
EsoBiotec Begins Clinical Trial of In Vivo BCMA CAR-T Candidate ESO-T01 for Multiple Myeloma
ESO-T01 is the first in vivo BCMA CAR-T candidate to reach the clinical stageEarly clinical data are expected in second half of ...
health.economictimes.indiatimes18h
DBT & CSCR executes India’s first Human Gene Therapy for Hemophilia A patients
In the groundbreaking study the researchers observed an annualised zero bleeding rate in all the five subjects enrolled with ...
India Today18h
India makes big breakthrough in treating genetic disorder Hemophilia A
India has successfully conducted its first in-human gene therapy for hemophilia A, with patients experiencing no bleeding ...
eLife11h
Rab10 inactivation promotes AMPAR insertion and spine enlargement during long-term potentiation
Among these sensors, we further focused on the spatiotemporal dynamics of Rab10 and Rab4 activity during sLTP. We found that postsynaptic stimulation leads to the persistent inactivation of Rab10 and ...